3,900
Participants
Start Date
October 31, 2019
Primary Completion Date
August 10, 2023
Study Completion Date
August 10, 2023
Ad26.Mos4.HIV
Participants will receive Ad26.Mos4.HIV via IM injection into the deltoid muscle at months 0 (Day 1), 3, 6 and 12.
Clade C and Mosaic gp140 HIV bivalent vaccine
Participants will receive Clade C and Mosaic gp140 HIV bivalent vaccine as IM injection into the deltoid muscle at Months 6 and 12.
Placebo
Participants will receive matching placebo.
Harlem Prevention Center CRS, New York
Columbia University Medical Center, New York
New York Blood Center, New York
Inst. Nal. de Ciencias Med. Y Nutricion Salvador Zubiran, Mexico City
Hosp Reina Sofia, Córdoba
Strong Memorial Infectious Disease, Rochester
Asociacion Civil Via Libre, Lima
Asociacion Civil Impacta Salud y Educacion- San Miguel CRS, Lima - San Miguel
Asociacion Civil Selva Amazonica (ACSA), Iquitos
University of Pennsylvania, Philadelphia
Ospedale San Raffaele, Milan
Whitman Walker Health, Washington D.C.
Hosp Univ Fund Jimenez Diaz, Madrid
Hosp. Clinico San Carlos, Madrid
The Hope Clinic at Emory University, Decatur
Emory University Rollins School of Public Health - Ponce De Leon CRS, Atlanta
Orlando Immunology Center, Orlando
University of Miami, Miami
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena
Hospital Civil Fray Antonio Alcalde, Guadalajara
Hosp. Gral. Univ. Valencia, Valencia
University Of Illinois, Chicago
New Orleans Adolescent Trials Unit CRS, New Orleans
Gordon E. Crofoot MD, Houston
Bridge HIV, San Francisco
Unidad de Atención Medica e Investigacion en Salud (UNAMIS), Mérida
Seattle Vaccine Trials Unit, Seattle
Dana-Farber/Brigham and Women's Hospital, Boston
Fenway Health, Boston
Rutgers, The State University of New Jersey - The University Hospital/ACTG Network, Newark
Helios Salud Sa, Buenos Aires
Fundacion Huesped, Ciudad Autonoma de Buenos Aire
Hospital J. M. Ramos Mejía, Ciudad de Buenos Aires
Instituto Caici Srl., Rosario
Universidade Federal De Minas Gerais - Hospital das Clínicas, Belo Horizonte
Centro Medico Sao Francisco, Curitiba
Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado - FMT, Manaus
Fundacao Oswaldo Cruz, Rio de Janeiro
Municipio de Nova Iguacu - Hospital Geral de Nova Iguacu, Rio de Janeiro
Instituto de infectologia Emilio Ribas, São Paulo
Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo
Centro de Referencia E Treinamento Dst/Aids, São Paulo
Istituto nazionale malattie infettive 'L. Spallanzani', Roma
Centro de Investigaciones Tecnologicas, Biomedica y medio ambientales (CITBM), Callao
Asociacion Civil Impacta Salud y Educacion - Barranco, Lima - Barranco
Neutrum Lekarze M.Hlebowicz i Partnerzy spolka partnerska, Gdansk
Wroclawskie Centrum Zdrowia SPZOZ, Poradnia Profilaktyczno-Lecznicza, Wroclaw
Clinical Research Puerto Rico Inc, San Juan
University of Puerto Rico, San Juan
Hosp. Univ. Germans Trias I Pujol, Badalona
Hosp. Univ. Vall D Hebron, Barcelona
Janssen Vaccines & Prevention B.V.
INDUSTRY